Evidence map›Paper›PMID 39948308›Full record

ArticleNature cardiovascular research2025

Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin.

Ken-Ichi Hirano, Satomi Okamura, Koichiro Sugimura, Hideyuki Miyauchi, Yusuke Nakano, Kotaro Nochioka, Chikako Hashimoto, Yoshitaka Iwanaga, Kenichi Nakajima, Satoshi Yamaguchi and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Diagnostic Principle with Washout Rate ofAnnals of nuclear cardiology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Ken-Ichi HiranoDepartment of Triglyceride Science, Graduate School of Medicine, Osaka University, Osaka, Japan. khirano@cnt-osaka.com.ORCID http://orcid.org/0000-0002-3535-957X
Satomi OkamuraDepartment of Medical Innovation, Osaka University Hospital, Osaka, Japan.
Koichiro SugimuraDepartment of Cardiovascular Medicine, Tohoku University, Graduate School of Medicine, Miyagi, Japan.ORCID http://orcid.org/0000-0001-5354-9687
Hideyuki MiyauchiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Yusuke NakanoDepartment of Cardiology, Aichi Medical University, Aichi, Japan.
Kotaro NochiokaDepartment of Cardiovascular Medicine, Tohoku University, Graduate School of Medicine, Miyagi, Japan.ORCID http://orcid.org/0000-0001-8297-8624
Chikako HashimotoTGCV/NLSD Patient Association, Osaka, Japan.
Yoshitaka IwanagaDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kenichi NakajimaDepartment of Functional Imaging and Artificial Intelligence, Kanazawa University, Kanazawa, Japan.
Satoshi YamaguchiThe Tochino Foundation, Osaka, Japan.
Yoko YasuiTGCV/NLSD Patient Association, Osaka, Japan.
Shinsaku ShimamotoDepartment of Cardiology, Itami City Hospital, Hyogo, Japan.
Makito HiranoDepartment of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.
Mana OkuneDepartment of Cardiovascular Medicine, Kindai University Faculty of Medicine, Osaka, Japan.
Yuki NishimuraDepartment of Medical Innovation, Osaka University Hospital, Osaka, Japan.
Hisashi ShimoyamaDepartment of Cardiology, Itami City Hospital, Hyogo, Japan.
Yasuyuki NagasawaDepartment of General Internal Medicine, Hyogo Medical University, Hyogo, Japan.
Tetsuya AmanoDepartment of Cardiology, Aichi Medical University, Aichi, Japan.
Shimpei KuniyoshiDepartment of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Shu-Ping HuiFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID http://orcid.org/0000-0001-9973-6461
Nobuhiro ZaimaDepartment of Applied Biological Chemistry, Graduate School of Agriculture, Kindai University, Nara, Japan.
Yoshihiko IkedaDepartment of Triglyceride Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
Tomomi YamadaDepartment of Medical Innovation, Osaka University Hospital, Osaka, Japan.
Shinichiro FujimotoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasuhiko SakataDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kunihisa KobayashiDepartment of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-7741-846X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart disease is a major global threat. Triglyceride deposit cardiomyovasculopathy (TGCV) is an emerging, noncommunicable, adult-onset heart disease, first identified in Japanese patients with heart failure (HF) requiring cardiac transplantation

Indexed as

CardiomyopathiesHeart FailureLipolysisMyocardiumTriglyceridesAdultAgedFemaleHumansMaleMiddle AgedRecovery of FunctionRegistriesTime FactorsTreatment OutcomeTriglycerides

Identifiers

PMID39948308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.